- Home
- REFR vs MDAI Comparison
REFR vs MDAI Comparison
Compare REFR & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REFR
- MDAI
- Stock Information
- Founded
- REFR 1965
- MDAI 2013
- Country
- REFR United States
- MDAI United States
- Employees
- REFR N/A
- MDAI N/A
- Industry
- REFR Multi-Sector Companies
- MDAI Medical/Dental Instruments
- Sector
- REFR Miscellaneous
- MDAI Health Care
- Exchange
- REFR Nasdaq
- MDAI Nasdaq
- Market Cap
- REFR 61.4M
- MDAI 69.0M
- IPO Year
- REFR N/A
- MDAI N/A
- Fundamental
- Price
- REFR $1.51
- MDAI $2.41
- Analyst Decision
- REFR
- MDAI Strong Buy
- Analyst Count
- REFR 0
- MDAI 2
- Target Price
- REFR N/A
- MDAI $4.75
- AVG Volume (30 Days)
- REFR 39.0K
- MDAI 500.0K
- Earning Date
- REFR 08-07-2025
- MDAI 08-12-2025
- Dividend Yield
- REFR N/A
- MDAI N/A
- EPS Growth
- REFR N/A
- MDAI N/A
- EPS
- REFR N/A
- MDAI N/A
- Revenue
- REFR $1,581,929.00
- MDAI $29,962,000.00
- Revenue This Year
- REFR N/A
- MDAI N/A
- Revenue Next Year
- REFR N/A
- MDAI $15.15
- P/E Ratio
- REFR N/A
- MDAI N/A
- Revenue Growth
- REFR 62.28
- MDAI 55.21
- 52 Week Low
- REFR $0.93
- MDAI $0.82
- 52 Week High
- REFR $2.39
- MDAI $3.25
- Technical
- Relative Strength Index (RSI)
- REFR 45.10
- MDAI 47.07
- Support Level
- REFR $1.52
- MDAI $2.34
- Resistance Level
- REFR $1.70
- MDAI $2.55
- Average True Range (ATR)
- REFR 0.14
- MDAI 0.17
- MACD
- REFR -0.02
- MDAI -0.04
- Stochastic Oscillator
- REFR 20.21
- MDAI 16.67
About REFR Research Frontiers Incorporated
Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. The company's revenue source comes from the licensing of technology.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.